Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT03020420 |
| Other study ID # |
Cicatricell |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
March 2015 |
| Est. completion date |
December 2020 |
Study information
| Verified date |
June 2024 |
| Source |
University of Toledo |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
This study tries to prove that Cicatricell cream significantly reduces scarring with better
wound appearance as compared to no treatment.
Description:
At 1st post operative follow up visit, surgical incision(s) will be assessed for healing,
after the sutures/staples/steri-strips are removed. To be included in the study the incision
must be 5cm or greater. And bilateral incisions as in bilateral mastectomy can be included.
The incisions will be divided into two sections, using an imaginary line between top and
bottom, or left and right. One side of the imaginary line will have cicatricell cream applied
2 times a day for a minimum of 8 weeks and a maximum 6months. The other side of the imaginary
line will remain untreated. In the case of a bilateral incision, as in bilateral breast
mastectomy or AAA incisions in the groins, the cream will be applied to one entire incision
and the 2nd incision will be untreated. The incision(s) will be its own control group. At the
end of the treatment phase the incision(s) will be assessed again to compare the healing.